LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 4 of 15: Mean cell count and mean growth rate across biological replicate 1. - Dataset (ID:20240)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
Hs 578T | Dasatinib | 0.04 | uM | LJP5 | 72 | hr | 929 | 2282 | 3228 | 0.7070 | 0.5886 |
Hs 578T | Dovitinib | 0.04 | uM | LJP5 | 72 | hr | 929 | 2551 | 3228 | 0.7904 | 0.7056 |
Hs 578T | Enzastaurin | 0.04 | uM | LJP5 | 72 | hr | 929 | 3281 | 3228 | 1.0165 | 1.0232 |
Hs 578T | Pictilisib | 0.04 | uM | LJP6 | 72 | hr | 929 | 2559 | 3228 | 0.7927 | 0.7090 |
Hs 578T | Gefitinib | 0.04 | uM | LJP6 | 72 | hr | 929 | 3235 | 3228 | 1.0021 | 1.0030 |
Hs 578T | Geldanamycin | 0.04 | uM | LJP6 | 72 | hr | 929 | 2701 | 3228 | 0.8368 | 0.7709 |
Hs 578T | GSK1059615 | 0.04 | uM | LJP5 | 72 | hr | 929 | 3168 | 3228 | 0.9816 | 0.9742 |
Hs 578T | Omipalisib | 0.04 | uM | LJP6 | 72 | hr | 929 | 1409 | 3228 | 0.4366 | 0.2088 |
Hs 578T | GSK 690693 | 0.04 | uM | LJP5 | 72 | hr | 929 | 2630 | 3228 | 0.8149 | 0.7401 |
Hs 578T | HG-5-113-01 | 0.04 | uM | LJP5 | 72 | hr | 929 | 3070 | 3228 | 0.9512 | 0.9315 |
Hs 578T | HG-5-88-01 | 0.04 | uM | LJP6 | 72 | hr | 929 | 3095 | 3228 | 0.9588 | 0.9421 |
Hs 578T | Linifanib | 0.04 | uM | LJP6 | 72 | hr | 929 | 3168 | 3228 | 0.9814 | 0.9739 |
Hs 578T | Linsitinib | 0.04 | uM | LJP5 | 72 | hr | 929 | 3174 | 3228 | 0.9834 | 0.9766 |
Hs 578T | Mitoxantrone | 0.04 | uM | LJP6 | 72 | hr | 929 | 1329 | 3228 | 0.4117 | 0.1739 |
Hs 578T | MK2206 | 0.04 | uM | LJP6 | 72 | hr | 929 | 2927 | 3228 | 0.9067 | 0.8690 |
Hs 578T | Nintedanib | 0.04 | uM | LJP6 | 72 | hr | 929 | 2947 | 3228 | 0.9131 | 0.8780 |
Hs 578T | NU7441 | 0.04 | uM | LJP5 | 72 | hr | 929 | 3193 | 3228 | 0.9893 | 0.9850 |
Hs 578T | NVP-TAE684 | 0.04 | uM | LJP6 | 72 | hr | 929 | 2877 | 3228 | 0.8915 | 0.8476 |
Hs 578T | Palbociclib | 0.04 | uM | LJP6 | 72 | hr | 929 | 2313 | 3228 | 0.7165 | 0.6019 |
Hs 578T | PD184352 | 0.04 | uM | LJP5 | 72 | hr | 929 | 2483 | 3228 | 0.7692 | 0.6759 |
Hs 578T | Pelitinib | 0.04 | uM | LJP5 | 72 | hr | 929 | 3215 | 3228 | 0.9961 | 0.9945 |
Hs 578T | PF477736 | 0.04 | uM | LJP5 | 72 | hr | 929 | 3161 | 3228 | 0.9793 | 0.9710 |
Hs 578T | PF562271 | 0.04 | uM | LJP6 | 72 | hr | 929 | 2878 | 3228 | 0.8918 | 0.8480 |
Hs 578T | Nilotinib | 0.37 | uM | LJP5 | 72 | hr | 929 | 3705 | 3228 | 1.1480 | 1.2078 |
Hs 578T | Neratinib | 0.37 | uM | LJP5 | 72 | hr | 929 | 2418 | 3228 | 0.7493 | 0.6479 |